Savara Inc Stock Investor Sentiment
| SVRA Stock | USD 3.36 0.11 3.17% |
About 62% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
Savara |
Savara Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Savara can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Savara that are available to investors today. That information is available publicly through Savara media outlets and privately through word of mouth or via Savara internal channels. However, regardless of the origin, that massive amount of Savara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Savara news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Savara relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Savara's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Savara alpha.
Savara Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Mathers Edward T of 333333 shares of Savara at 3.0 subject to Rule 16b-3 | 09/13/2024 |
2 | Acquisition by Pratt Raymond Dennis of 3500 shares of Savara at 1.5434 subject to Rule 16b-3 | 09/20/2024 |
3 | Savara Announces Expanded Access Program for Molgramostim Inhalation Solution for Patients with Autoimmune Pulmonary Alveolar Proteinosis | 09/27/2024 |
4 | Acquisition by Elam Nevan C of 1758 shares of Savara at 0.82 subject to Rule 16b-3 | 10/17/2024 |
5 | Disposition of 381 shares by Anne Erickson of Savara at 3.57 subject to Rule 16b-3 | 10/21/2024 |
6 | Savara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis , is Highlighted on a New Episode of The Balancing Act Airing on Lifetime TV | 10/22/2024 |
7 | Disposition of 49950 shares by Pratt Raymond Dennis of Savara at 3.97 subject to Rule 16b-3 | 11/08/2024 |
8 | Jennison Associates LLCs Strategic Acquisition of Savara Inc Shares | 11/13/2024 |
9 | Acquisition by Ramsay David A of 100000 shares of Savara at 2.876 subject to Rule 16b-3 | 11/18/2024 |
10 | Director David Ramsay Acquires 100,000 Shares of Savara Inc | 11/19/2024 |
11 | Independent Director of Savara Picks Up 4.5 percent More Stock | 11/21/2024 |
12 | Savara Announces Encore Presentation of Results from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution in Patients with Autoimmune Pulmonary Alveol... | 11/22/2024 |
13 | Estimating The Fair Value Of Savara Inc. | 11/25/2024 |
14 | Vestal Point Capital LP Raises Holdings in Savara Inc | 11/29/2024 |
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |